Saad F - Search Results

1

Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases.

Saad F, Brown JE, Van Poznak C, Ibrahim T, Stemmer SM, Stopeck AT, Diel IJ, Takahashi S, Shore N, Henry DH, Barrios CH, Facon T, Senecal F, Fizazi K, Zhou L, Daniels A, Carrière P, Dansey R. Saad F, et al. Ann Oncol. 2012 May;23(5):1341-1347. doi: 10.1093/annonc/mdr435. Epub 2011 Oct 10. Ann Oncol. 2012. PMID: 21986094 Free article.

2

Zoledronic acid significantly reduces pathologic fractures in patients with advanced-stage prostate cancer metastatic to bone.

Saad F. Saad F. Clin Prostate Cancer. 2002 Dec;1(3):145-52. doi: 10.3816/cgc.2002.n.016. Clin Prostate Cancer. 2002. PMID: 15046689 Review.

3

The role of bisphosphonates in the management of bone metastases in prostate cancer.

Saad F, Chi K, Fleshner N. Saad F, et al. Can J Urol. 2004 Oct;11(5):2376-82. Can J Urol. 2004. PMID: 15576002 Review.

4

Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors.

Brown JE, Cook RJ, Major P, Lipton A, Saad F, Smith M, Lee KA, Zheng M, Hei YJ, Coleman RE. Brown JE, et al. Among authors: saad f. J Natl Cancer Inst. 2005 Jan 5;97(1):59-69. doi: 10.1093/jnci/dji002. J Natl Cancer Inst. 2005. PMID: 15632381

5

The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer.

Weinfurt KP, Li Y, Castel LD, Saad F, Timbie JW, Glendenning GA, Schulman KA. Weinfurt KP, et al. Among authors: saad f. Ann Oncol. 2005 Apr;16(4):579-84. doi: 10.1093/annonc/mdi122. Epub 2005 Feb 25. Ann Oncol. 2005. PMID: 15734776 Free article.

6

Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid.

Coleman RE, Major P, Lipton A, Brown JE, Lee KA, Smith M, Saad F, Zheng M, Hei YJ, Seaman J, Cook R. Coleman RE, et al. Among authors: saad f. J Clin Oncol. 2005 Aug 1;23(22):4925-35. doi: 10.1200/JCO.2005.06.091. Epub 2005 Jun 27. J Clin Oncol. 2005. PMID: 15983391

7

Effect of zoledronic acid on pain associated with bone metastasis in patients with prostate cancer.

Weinfurt KP, Anstrom KJ, Castel LD, Schulman KA, Saad F. Weinfurt KP, et al. Among authors: saad f. Ann Oncol. 2006 Jun;17(6):986-9. doi: 10.1093/annonc/mdl041. Epub 2006 Mar 13. Ann Oncol. 2006. PMID: 16533874 Free article. Clinical Trial.

8

Markers of bone metabolism and survival in men with hormone-refractory metastatic prostate cancer.

Cook RJ, Coleman R, Brown J, Lipton A, Major P, Hei YJ, Saad F, Smith MR. Cook RJ, et al. Among authors: saad f. Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3361-7. doi: 10.1158/1078-0432.CCR-06-0269. Clin Cancer Res. 2006. PMID: 16740758 Clinical Trial.

9

Pathologic fractures correlate with reduced survival in patients with malignant bone disease.

Saad F, Lipton A, Cook R, Chen YM, Smith M, Coleman R. Saad F, et al. Cancer. 2007 Oct 15;110(8):1860-7. doi: 10.1002/cncr.22991. Cancer. 2007. PMID: 17763372 Free article. Clinical Trial.

10

Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel.

Aapro M, Abrahamsson PA, Body JJ, Coleman RE, Colomer R, Costa L, Crinò L, Dirix L, Gnant M, Gralow J, Hadji P, Hortobagyi GN, Jonat W, Lipton A, Monnier A, Paterson AH, Rizzoli R, Saad F, Thürlimann B. Aapro M, et al. Among authors: saad f. Ann Oncol. 2008 Mar;19(3):420-32. doi: 10.1093/annonc/mdm442. Epub 2007 Sep 28. Ann Oncol. 2008. PMID: 17906299 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,348 results

Search Page